This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xiang, Y. Articles by Leis, J. Search for Related Content PubMed PubMed Citation Articles by Xiang, Y. Articles by Leis, J.

 Previous Article  |  Next Article 

J. Virol., 03 1997, 2083-2091, Vol 71, No. 3
Copyright © 1997, American Society for Microbiology

Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation

Y Xiang, TW Ridky, NK Krishna and J Leis
Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.

Proteolytic processing of the Rous sarcoma virus (RSV) Gag precursor was altered in vivo through the introduction of amino acid substitutions into either the polyprotein cleavage junctions or the PR coding sequence. Single amino acid substitutions (V(P2)S and P(P4)G), which are predicted from in vitro peptide substrate cleavage data to decrease the rate of release of PR from the Gag polyprotein, were placed in the NC portion of the NC-PR junction. These substitutions do not affect the efficiency of release of virus-like particles from COS cells even though recovered particles contain significant amounts of uncleaved Pr76gag in addition to mature viral proteins. Single amino acid substitutions (A(P3)F and S(P1)Y), which increase the rate of PR release from Gag, also do not affect budding of virus-like particles from cells. Substitution of the inefficiently cleaved MA-p2 junction sequence in Gag by eight amino acids from the rapidly cleaved NC-PR sequence resulted in a significant increase in cleavage at the new MA- p2 junction, but again without an effect on budding. However, decreased budding was observed when the A(P3)F or S(P1)Y substitution was included in the NC-PR junction sequence between the MA and p2 proteins. A budding defect was also caused by substitution into Gag of a PR subunit containing three amino acid substitutions (R105P, G106V, and S107N) in the substrate binding pocket that increase the catalytic activity of PR. The defect appears to be the result of premature proteolytic processing that could be rescued by inactivating PR through substitution of a serine for the catalytic aspartic acid residue. This budding defect was also rescued by single amino acid substitutions in the NC-PR cleavage site which decrease the rate of release of PR from Gag. A similar budding defect was caused by replacing the Gag PR with two PR subunits covalently linked by four glycine residues. In contrast to the defect caused by the triply substituted PR, the budding defect observed with the linked PR dimer could not be rescued by NC-PR cleavage site mutations, suggesting that PR dimerization is a limiting step in the maturation process. Overall, these results are consistent with a model in which viral protein maturation occurs after PR subunits are released from the Gag polyprotein.

This article has been cited by other articles:

• Chiu, H.-C., Wang, F.-D., Chen, Y.-M. A., Wang, C.-T. (2006). Effects of human immunodeficiency virus type 1 transframe protein p6* mutations on viral protease-mediated Gag processing. J. Gen. Virol. 87: 2041-2046 [Abstract] [Full Text]  
• Pettit, S. C., Everitt, L. E., Choudhury, S., Dunn, B. M., Kaplan, A. H. (2004). Initial Cleavage of the Human Immunodeficiency Virus Type 1 GagPol Precursor by Its Activated Protease Occurs by an Intramolecular Mechanism. J. Virol. 78: 8477-8485 [Abstract] [Full Text]  
• Le Blanc, I., Prevost, M.-C., Dokhelar, M.-C., Rosenberg, A. R. (2002). The PPPY Motif of Human T-Cell Leukemia Virus Type 1 Gag Protein Is Required Early in the Budding Process. J. Virol. 76: 10024-10029 [Abstract] [Full Text]  
• Parker, S. D., Hunter, E. (2001). Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro. Proc. Natl. Acad. Sci. USA 10.1073/pnas.251460998v1 [Abstract] [Full Text]  
• Krishna, N. K., Wills, J. W. (2001). Insertion of Capsid Proteins from Nonenveloped Viruses into the Retroviral Budding Pathway. J. Virol. 75: 6527-6536 [Abstract] [Full Text]  
• Bowzard, J. B., Visalli, R. J., Wilson, C. B., Loomis, J. S., Callahan, E. M., Courtney, R. J., Wills, J. W. (2000). Membrane Targeting Properties of a Herpesvirus Tegument Protein-Retrovirus Gag Chimera. J. Virol. 74: 8692-8699 [Abstract] [Full Text]  
• Wang, C.-T., Chou, Y.-C., Chiang, C.-C. (2000). Assembly and Processing of Human Immunodeficiency Virus Gag Mutants Containing a Partial Replacement of the Matrix Domain by the Viral Protease Domain. J. Virol. 74: 3418-3422 [Abstract] [Full Text]  
• Garnier, L., Ratner, L., Rovinski, B., Cao, S.-X., Wills, J. W. (1998). Particle Size Determinants in the Human Immunodeficiency Virus Type 1 Gag Protein. J. Virol. 72: 4667-4677 [Abstract] [Full Text]  
• Krishna, N. K., Campbell, S., Vogt, V. M., Wills, J. W. (1998). Genetic Determinants of Rous Sarcoma Virus Particle Size. J. Virol. 72: 564-577 [Abstract] [Full Text]  
• Sharma, S., Murai, F., Miyanohara, A., Friedmann, T. (1997). Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents. Proc. Natl. Acad. Sci. USA 94: 10803-10808 [Abstract] [Full Text]  
• Parker, S. D., Hunter, E. (2001). Activation of the Mason-Pfizer monkey virus protease within immature capsids invitro. Proc. Natl. Acad. Sci. USA 98: 14631-14636 [Abstract] [Full Text]